INFINIUMPharmaceuticals
Infinium Pharmachem Ltd — PE Ratio & Valuation Analysis
₹192.80
-0.37%
Current P/E39.73xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E31.4x26.5% above avg
⚠️
25.1% Premium to Industry
INFINIUM P/E 39.73x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2024 | ₹10.61 | ₹300 | 28.3x |
| 2023 | ₹6.82 | ₹235 | 34.5x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Infinium Pharmachem Ltd Valuation
Infinium Pharmachem Ltd (INFINIUM) currently trades at 39.73x earnings. The Pharmaceuticals sector average PE is 31.77x. INFINIUM commands a premium, reflecting high growth expectations. Historically, INFINIUM has traded at an average PE of 31.4x — it is currently above that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
11.95%
Dividend Yield
0.00%
More on Infinium Pharmachem Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.